Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingfeng Chen

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Frontiers in Pharmacology|February 27, 2023
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl<sub>4</sub>-induced liver fibrosisYi Zhang, Binhao Cai, Yingying Li, et al.
Drug Design, Development and Therapy|May 3, 2018
Design, synthesis, and structure-activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injurySiyang Xiao, Wenxin Zhang, Hongjin Chen, et al.
Diabetes|February 23, 2024
Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB- Dependent InflammationXue Han, Jiajia Wei, Ruyi Zheng, et al.
European Journal of Medicinal Chemistry|February 22, 2018
New MD2 inhibitors derived from curcumin with improved anti-inflammatory activityYali Zhang, Zhiguo Liu, Jianzhang Wu, et al.
Frontiers in Pharmacology|April 3, 2023
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathwayLenan Xu, Meiling Zhang, Junzhi Pan, et al.
European Journal of Medicinal Chemistry|May 17, 2025
Discovery of LC-SF-14, a selective dual inhibitor of SHP2 and FGFR for the treatment of FGFR2-driven gastric cancerLei Zheng, Yuhan Wang, Zheng Jiang, et al.
Translational Vision Science & Technology|March 4, 2025
Evaluation of the Long-Term Corneal Biomechanics Following SMILE With Different Residual Stromal Bed Thickness in RabbitsHongwei Qin, Xin Yang, Rui He, et al.
Veterinary Microbiology|October 21, 2015
Molecular and antigenic characteristics of Massachusetts genotype infectious bronchitis coronavirus in ChinaLingfeng Chen, Tingting Zhang, Zongxi Han, et al.
Journal of Medicinal Chemistry|May 23, 2023
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric CancerLin Ma, Yingying Li, Ruixiang Luo, et al.
Journal of Nanobiotechnology|January 24, 2026
Microneedle-delivered ROS-adaptive asiatic acid nanoparticles promote scarless repair via remodeling the pathological microenvironmentYawen Zhang, Xuanyu Tang, Yijing Ma, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Frontiers in Pharmacology|February 27, 2023
Identification of linderalactone as a natural inhibitor of SHP2 to ameliorate CCl<sub>4</sub>-induced liver fibrosisYi Zhang, Binhao Cai, Yingying Li, et al.
Drug Design, Development and Therapy|May 3, 2018
Design, synthesis, and structure-activity relationships of 2-benzylidene-1-indanone derivatives as anti-inflammatory agents for treatment of acute lung injurySiyang Xiao, Wenxin Zhang, Hongjin Chen, et al.
Diabetes|February 23, 2024
Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB- Dependent InflammationXue Han, Jiajia Wei, Ruyi Zheng, et al.
European Journal of Medicinal Chemistry|February 22, 2018
New MD2 inhibitors derived from curcumin with improved anti-inflammatory activityYali Zhang, Zhiguo Liu, Jianzhang Wu, et al.
Frontiers in Pharmacology|April 3, 2023
Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathwayLenan Xu, Meiling Zhang, Junzhi Pan, et al.
European Journal of Medicinal Chemistry|May 17, 2025
Discovery of LC-SF-14, a selective dual inhibitor of SHP2 and FGFR for the treatment of FGFR2-driven gastric cancerLei Zheng, Yuhan Wang, Zheng Jiang, et al.
Translational Vision Science & Technology|March 4, 2025
Evaluation of the Long-Term Corneal Biomechanics Following SMILE With Different Residual Stromal Bed Thickness in RabbitsHongwei Qin, Xin Yang, Rui He, et al.
Veterinary Microbiology|October 21, 2015
Molecular and antigenic characteristics of Massachusetts genotype infectious bronchitis coronavirus in ChinaLingfeng Chen, Tingting Zhang, Zongxi Han, et al.
Journal of Medicinal Chemistry|May 23, 2023
Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric CancerLin Ma, Yingying Li, Ruixiang Luo, et al.
Journal of Nanobiotechnology|January 24, 2026
Microneedle-delivered ROS-adaptive asiatic acid nanoparticles promote scarless repair via remodeling the pathological microenvironmentYawen Zhang, Xuanyu Tang, Yijing Ma, et al.
Pageof 13